Obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-cell lymphoma: Final results from an open-label, randomized phase 3 study (GOYA)

This article has no abstract
Epistemonikos ID: ebbd669008e623142fbcfeb8d049f7a5b5b73378
First added on: Feb 08, 2025